Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

被引：56
|
作者：
Couriel, DR [1 ]
Hicks, K [1 ]
Giralt, S [1 ]
Champlin, RE [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Div Med, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA
来源：
CURRENT OPINION IN ONCOLOGY | 2000年 / 12卷 / 06期
关键词：
D O I：
10.1097/00001622-200011000-00011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor necrosis factor (TNF)-alpha is a central cytotoxic and proinflammatory cytokine, Research on the benefits of TNF-alpha inhibition as a form of therapy has focused almost exclusively on autoimmune, inflammatory disorders. InflixiMAB, a chimeric antibody to human TNF-alpha, was recently approved for the management of Crohn disease and rheumatoid arthritis. The potential applications of inflixiMAB in the management of cancer are just beginning to be explored. This article reviews the biology, mechanism of action, pharmacology, and toxicity of inflixiMAB. Existing clinical experience and inflixiMAB's potential role as an immunosuppressant and antitumor agent in the management of cancer are also discussed. Curr Opin Oncol 2000, 12:582-587 (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码：582 / 587
页数：6
相关论文
共 50 条
  • [1] Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha
    Cai, Weibo
    Kerner, Zachary J.
    Hong, Hao
    Sun, Jiangtao
    BIOCHEMISTRY INSIGHTS, 2008, 1 : 5 - 21
  • [2] Abrogation of radiation injury to human hematopoietic stem cells with tumor necrosis factor-alpha
    Karkanitsa, LV
    Komarovskaya, ME
    Krivenko, SI
    STEM CELLS, 1997, 15 : 95 - 102
  • [3] ROLE OF TUMOR NECROSIS FACTOR-ALPHA INHIBITION FOLLOWING SPINAL CORD INJURY
    Ellman, D. G.
    Bracchi-Ricard, V.
    Novrup, H. G.
    Jain, A.
    Lyck, L.
    Lykkemark, L.
    Szymkowski, D. E.
    Pearse, D. E.
    Bethea, J. R.
    Lambertsen, K. L.
    GLIA, 2013, 61 : S197 - S197
  • [4] Role of Tumor Necrosis Factor-Alpha in Rheumatoid Arthritis
    Link, Tina
    Kepner, Alisa
    Coruso, Olivia
    Dilip, Megha
    Jacobson, Reagan
    Stanovski, Lisa
    FASEB JOURNAL, 2018, 32 (01):
  • [5] Antisense strategies for inhibition of tumor necrosis factor-alpha synthesis
    Hartmann, G
    Krug, A
    Bidlingmaier, M
    Eigler, A
    Endres, S
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (5-6): : 629 - 634
  • [6] Circulating bioactive tumor necrosis factor-alpha, tumor necrosis factor-alpha receptors, fibronectin, and tumor necrosis factor-alpha inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancy
    Beckmann, I
    Visser, W
    Struijk, PC
    vanDooren, M
    Glavimans, J
    Wallenburg, HCS
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (05) : 1247 - 1252
  • [7] Infection and anti-tumor necrosis factor-alpha therapy
    Zandman-Goddard, G
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (11): : 814 - 816
  • [8] Role of tumor necrosis factor-alpha in the ovulatory mechanism of ewes
    Murdoch, WJ
    Colgin, DC
    Ellis, JA
    JOURNAL OF ANIMAL SCIENCE, 1997, 75 (06) : 1601 - 1605
  • [9] The role of tumor necrosis factor-alpha in systemic lupus erythematosus
    Martin Aringer
    Josef S Smolen
    Arthritis Research & Therapy, 10
  • [10] Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation
    DENG HaiXUE YumeiZHAN XianzhangLIAO HongtaoGUO Huiming and WU Shulin Department of CardiologyGuangdong Cardiovascular Institute Guangdong General HospitalGuangdong Academy of Medical SciencesGuangzhouGuangdong China
    中华医学杂志（英文版）, 2011, (13) : 1976 - 1982
12345